• HOME
  • TFOS DEWS II REPORT
  • SPONSORS
logo
  • HOME
  • TFOS DEWS II REPORT
  • SPONSORS
  • HOME
  • TFOS DEWS II REPORT
  • SPONSORS
    • ALCON
    • NOVARTIS
    • SHIRE
    • ALLERGAN
    • BAUSCH + LOMB
    • AKORN
    • COOPER VISION
    • DOMPÈ
    • HORUS
    • LUBRIS
    • OCULEVE
    • SUN PHARMA
    • TEAR LAB
    • THEA
    • SIFI
    • JOHNSON & JOHNSON
    • ZEISS
    • QUINT HEALTH
    • SCOPE
    • SENJU
  • TFOS DEWS II Steering Committee
  • Objectives
  • TFOS DEWS II subcommittees
  • Workshop process & progress
  • Subcommittee issues, controversies, and advancements
  • Dedication
  • Financial disclosures
  • References
  • Consultant
  • Acknowledgments

TFOS DEWS II - Objectives

The TFOS DEWS II Steering Committee committed to an evidence-based approach and a process of open communication, dialogue and transparency, in order to achieve a consensus concerning multiple aspects of DED. The committee formulated the workshop objectives, which were to:
1. Update the definition, classification and diagnosis of DED;
2. Critically assess the etiology, mechanism, distribution and impact of this disorder; and
3. Address its management and therapy
Tear Film & Ocular Surface Society Boston, MA 02113 USA - © All Rights Reserved.
twitter - youtube - blog - linked in - download the TFOS app on the Appstore - download the TFOS App for Android
Questo sito utilizza cookie di profilazione propri e di siti terzi. Se vuoi saperne di più consula la cookie policy. Chiudendo questo banner acconsenti all'uso dei cookie. Grazie
Ok
Leggi di più